Genetic determinants of blood pressure reduction following potassium supplementation: and the candidates are...
de Denus
Simon
S
Dubé
Marie-Pierre
MP
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics*; D015331:Cohort Studies; D019587:Dietary Supplements / Q000009:adverse effects; D019040:E-Selectin / Q000235:genetics; D019332:Endothelin-1 / Q000235:genetics*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D017419:Potassium, Dietary / Q000009:adverse effects / Q000627:therapeutic use*; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage
D019040:E-Selectin; D019332:Endothelin-1; D017419:Potassium, Dietary; C546936:SELE protein, human; D017673:Sodium Chloride, Dietary; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III